9330 Zionsville Road

Indianapolis, Indiana 46268

March 15, 2024

LETTER FROM CHAIRMAN

AND CHIEF EXECUTIVE OFFICER

NOTICE OF THE ANNUAL MEETING

OF STOCKHOLDERS

Dear Stockholder:

At the 20202024 Annual Meeting of Stockholders (the “2020“2024 Meeting”), stockholders will vote on the following matters either by proxy or in person:

How to Vote

Your vote is important. Whether or not you plan on attending the 20202024 Meeting, please vote your shares as soon as possible by internet, telephone or mail.

BY INTERNET   www.proxyvote.comFollow the instructions on your enclosed proxy card

BY PHONE   1-800-690-6903 orFollow the number provided instructions on your voting instructions enclosed proxy card

BY MAIL   Use the postage-paid envelope provided

The Board of Directors of Corteva, Inc. (the “Board”) has set the close of business on March 9, 2020,1, 2024, as the record date for determining stockholders who are entitled to receive notice of the 20202024 Meeting and to vote.

Proof of stock ownership is necessary to attend the 2024 Meeting. The 2024 Meeting will be a completely virtual meeting with no physical meeting location. Please see page 3 of the Proxy Statement for more information on attending virtually.

As permitted by U.S. Securities and Exchange Commission (the “SEC”) rules, proxy materials were made available via the internet. Notice regarding the availability of proxy materialsmaterial and instructions on how to access those materials were mailed to certain stockholders of record on or about March 19, 202015, 2024 (the “Notice”). TheThese instructions includedinclude how to vote online and how to request a paper copy of the proxy materials. This method of notice and access gives the Company the opportunity to deliver proxy materials to stockholders in a lower-cost way to furnish stockholders with their proxy materials.

Proof of stock ownership is necessary to attend the 2020 Meeting. Please see page 2 of the Proxy Statement for information on attending in person.lower cost, more environmentally sound manner.

Thank you for your continued support and your interest in Corteva, Inc.

Cornel B. Fuerer

Senior Vice President, General Counsel and Secretary

March 19, 202015, 2024

Cautionary Statement About Forward-Looking Statements

This proxy statementProxy Statement contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “projects,” “estimates”“estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s financial results or outlook; strategy for growth,growth; product development,development; regulatory approval,approvals; market position,position; capital allocation strategy; liquidity; sustainability targets, aspirations, and initiatives; the anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, or cost savings initiatives; and the outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, Inc., are forward-looking statements.

Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva’s control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva’s business, results of operations and financial condition. Some of the important factors that could cause Corteva’s actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to successfully develop and commercialize Corteva’s pipeline; (ii) effect of competition and consolidation in Corteva’s industry; (iii) failure to obtain or maintain the necessary regulatory approvals for some of Corteva’s products; (iv)(ii) failure to enforcesuccessfully develop and commercialize Corteva’s intellectual property rights or defend against intellectual property claims asserted by others; (v)pipeline; (iii) effect of competition from manufacturersthe degree of generic products; (vi) impactpublic understanding and acceptance or perceived public acceptance of Corteva’s dependence on third parties with respect to certainbiotechnology and other agricultural products; (iv) effect of its raw materials or licenseschanges in agricultural and commercialization; (vii)related policies of governments and international organizations; (v) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (vi) effect of climate change and unpredictable seasonal and weather factors; (vii) failure to comply with competition and antitrust laws; (viii) effect of the degreecompetition in Corteva’s industry; (ix) competitor’s establishment of public understanding and acceptance or perceived public acceptancean intermediary platform for distribution of Corteva’s biotechnologyproducts; (x) impact of Corteva’s dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xi) effect of volatility in Corteva’s input costs; (xii) risk related to geopolitical and military conflict; (xiii) risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the separation of Corteva; (xiv) risks related to Corteva’s global operations; (xv) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other agricultural products; (ix) effect of changes in agricultural and related policies of governments and international organizations; (x)portfolio actions; (xvi) effect of industrial espionage and other disruptions to Corteva’s supply chain, information technology or network systems; (xi) competitor’s establishment of an intermediary platform for distribution(xvii) failure of Corteva’s products; (xii) effect of volatility in Corteva’s input costs; (xiii)customers to pay their debts to Corteva, including customer financing programs; (xviii) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xiv) failure of Corteva’s customers to pay their debts to Corteva, including customer financing programs; (xv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva, including failure to benefit from significant cost synergies; (xvi) risks related to the indemnification obligations of legacy liabilities of E.I. du Pont de Nemours and Company (“EID”) in connection with the separation of Corteva; (xvii)(xix) increases in pension and other post-employment benefit plan funding obligations; (xviii) effect of compliance with laws and requirements and adverse judgments on litigation; (xix)(xx) capital markets sentiment towards sustainability matters; (xxi) risks related to pandemics or epidemics; (xxii) Corteva’s global operations; (xx) effect of climate change and unpredictable seasonal and weather factors; (xxi)intellectual property rights or defense against intellectual property claims asserted by others; (xxiii) effect of counterfeit products; (xxii) failure to effectively manage acquisitions, divestitures, alliances(xxiv) Corteva’s dependence on intellectual property cross-license agreements; and other portfolio actions; (xxiii) risks related to non-cash charges from impairment of goodwill or intangible assets; and (xxiv)(xxv) other risks related to the Separationour separation from DowDuPont, Inc.DowDuPont.

Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” in Part 1, Item 1A, of the Company’sour Annual Report on Form 10-K.

20202024 Annual Meeting of Stockholders

Corteva, Inc.

TABLE OF CONTENTS

Corteva 20202024 Proxy Statement | 1

PROXY STATEMENT SUMMARY

Annual Meeting of Stockholders

Meeting Agenda and Voting Recommendations

This summary highlights information contained elsewhere in this Proxy Statement. It does not contain all information that you should consider, and you should read the entire Proxy Statement carefully before voting.

		ANNUAL MEETING OF STOCKHOLDERS
		Date and Time		Place		Record Date
		April 26, 2024 8:00 a.m. Eastern Daylight Time		Virtually at: www.virtualshareholdermeeting.com/ CTVA2024		March 1, 2024

MEETING AGENDA AND VOTING RECOMMENDATIONS

Corteva 20202024 Proxy Statement | i

PROXY STATEMENT SUMMARY

Corteva’s Background and Formation

BackgroundCORTEVA’S BACKGROUND

Corteva Inc. (“Corteva” oris a U.S. based, pure-play agriculture company that provides farmers around the “Company”) combinesworld the strengths of E. I. du Pont de Nemoursmost complete portfolio in the industry — leveraging its global scale and Company’s Pioneercomprehensive routes to market to deliver innovative agriculture solutions to its farmer customers and Crop Protection businessescontribute to a sustainable global agricultural system. Corteva is ideally equipped to solve farmers’ productivity challenges through its balanced and the Dow Chemical Company’s agriculture science business to create a leading global providerdiverse portfolio of seed and crop protection solutions focused onofferings. Corteva leverages the agriculture industry. The Company is focused on advancingpower of its science-based innovation, which aimsunique distribution strategy, superior product pipeline, and unmatched customer relationships to deliver earnings growth, while taking actions across the organization to drive margin expansion and increase operating efficiency. At the same time, Corteva maintains a wide range of improved products and servicesdisciplined approach to capital allocation, balancing its customers. Through the combination of these innovation pipelines, Corteva has one of the broadest and most productive new product pipelines in the agriculture industry. The Company intends to leverage its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. New products are crucial to solving farmers’ productivity challenges amid a growing global population while addressing natural resistance, regulatory changes, safety requirements and competitive dynamics. The Company’s investment in technology-based and solution-based product offerings allows itongoing growth initiatives with enhancing the return of capital to meet farmers’ evolving needs while ensuring that its investments generate sufficient returns. Meanwhile, through Corteva’s unique routes to market, the Company continues to work face-to-face with farmers around the world to deeply understand their needs. The Company’s broad portfolio of agriculture solutions fuels farmer productivity in approximately 140 countries. Total worldwide employment at December 31, 2019 was about 21,000 people.

Our Formation

On June 1, 2019, Corteva became an independent, publicly traded company through the previously announced separation (the “Separation”) of the agriculture business of DuPont de Nemours, Inc. (formerly known as DowDuPont Inc.) (“DuPont” or “DowDuPont”). DowDuPont was formed on December 9, 2015 to effect an all-stock, merger of equals strategic combination between the Dow Chemical Company (“Historical Dow”) and E. I. du Pont de Nemours and Company (“Historical DuPont” or “EID”). On August 31, 2017, Historical Dow and Historical DuPont each merged with wholly owned subsidiaries of DowDuPont and, as a result of the mergers, Historical Dow and Historical DuPont became subsidiaries of DowDuPont (collectively, the “Merger”).

Subsequent to the Merger, Historical Dow and EID engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products through a series of tax-efficient transactions (collectively, the “Business Separations”).

In furtherance of the Business Separations, EID engaged in a series of internal reorganization and realignment steps (the “Internal Reorganization” and the “Business Realignment,” respectively) to realign its businesses into three subgroups: agriculture, materials science and specialty products. As part of the Internal Reorganization:

The Separation of Corteva was effectuated through a pro rata distribution of all of the then-issued and outstanding shares of common stock, par value $0.01 per share, of Corteva, Inc., which was then a wholly-owned subsidiary of DowDuPont, to holders of record of DowDuPont common stock as of the close of business on May 24, 2019 (the “Corteva Separation” and together with the Dow Distribution, the “Distributions”). As a result of the Internal Reorganization, on May 31, 2019, EID was contributed to Corteva and, as a result, Corteva, Inc. owns 100% of the outstanding common stock of EID. Prior to March 31, 2019, Corteva, Inc. had engaged in no business operations and had no assets or liabilities of any kind, other than those incident to its formation. On June 1, 2019, DowDuPont completed the Separation, and Corteva’s common stock began trading the “regular way” under the ticker symbol “CTVA” on June 3, 2019, the first business day after June 1, 2019.stockholders.

ii | Corteva 20202024 Proxy Statement

PROXY STATEMENT SUMMARY

In connection with the Separation, DowDuPont Inc. changed its name to DuPont de Nemours, Inc. With respect to this proxy statement, EID is referred to as Historical DuPont with respect to events occurring prior to the Internal Reorganization.

Director Nominees

You are being asked to vote on the election of 12 directors.13 directors: Lamberto Andreotti; Klaus A. Engel; David C. Everitt; Janet P. Giesselman; Karen H. Grimes; Michael O. Johanns; Rebecca B. Liebert; Marcos M. Lutz; Charles V. Magro, Nayaki R. Nayyar; Gregory R. Page; Kerry J. Preete; and Patrick J. Ward. All directors are elected annually. Detailed information about each nominee’sthe Board nominees’ background, skills, diversity, and expertise can be found inProposal 1 —Agenda Item 1: Election of Directors.

C = Chair

Corteva 20202024 Proxy Statement | iii

PROXY STATEMENT SUMMARY

Corporate Governance Best Practices

As partThe table below sets forth key metrics and attributes regarding our slate of Corteva’s commitment to high ethical standards, the Board follows sound governance practices. These practices, which are summarized below, are described in more detail beginning on page 4 of the Proxy Statement and on the Company’s website at www.investors.corteva.com/corporate-governance.director nominee slate.

iv | Corteva 2024 Proxy Statement

PROXY STATEMENT SUMMARY

The following summarizes key governance characteristics related to the executive compensation programs in which the named executive officers participate:

ivCorteva 2024 Proxy Statement | Corteva 2020 Proxy Statementv

VOTING AND ATTENDANCE PROCEDURES

In this Proxy Statement and the accompanying proxy material, including a proxy card, you will find information on the Board, of Directors of Corteva, Inc. (the “Board”), the candidatesBoard’s nominees for election to the Board, and fourtwo other agenda items to be voted upon at the 2020 Annual2024 Meeting of Stockholders (the “2020 Meeting”) and any adjournment or postponement of the 20202024 Meeting. The background information in this Proxy Statement has been supplied to you at the request of the Board to help you decide how to vote and to provide information on the Company’s corporate governance and compensation practices. This Proxy Statement isand the accompanying proxy card and other materials are first being distributed to stockholders on or about March 19, 2020.15, 2024.

Vote Your Shares in Advance

You may vote your shares by internet, telephone, or signing and returning the enclosed proxy or other voting instruction form.Your shares will be voted only if the proxy or voting instruction form is properly executed and received bybefore the independent Inspectors of Election prior topolls are closed at the 20202024 Meeting. Except as provided below with respect to shares held in employee savings plans, if no specific instructions are given by you when you execute your voting instruction form, as explained on the form, your shares will be voted as recommended by the Board.Board.

Changing Your Vote

You may change or revoke your proxy or voting instructions at any time before their use at the 20202024 Meeting by sending a written revocation, by(a) submitting another proxy or voting form on a later date, or by(b) attending the 2020 Meeting and voting in person. No matter which voting method you choose, however, you shouldat the 2024 Meeting. Your attendance at the 2024 Meeting will not vote any single account more than onceautomatically revoke your proxy unless you wish to change your vote.vote again at the 2024 Meeting. Be sure to submit votes for each separate account in which you hold Corteva common stock.

Recommendations of the Board

The Board recommends that you vote your shares on your proxy card or voting instruction form as follows:

Confidential Voting

The Company maintains vote confidentiality. Proxies and ballots of all stockholders are kept confidential from the Company’s management and Board unless disclosure is required by law and in other limited circumstances. TheOur policy further provides that employees may confidentially vote their shares of Company stock held by employee savings plans, and requires the appointment ofwe have appointed an independent tabulator and InspectorsInspector of Election for the 20202024 Meeting.

Dividend Reinvestment Plan Shares and Employee Savings Plan Shares

If you are enrolled in the direct stock purchase plan and the dividend reinvestment plan administered by Computershare Trust Company, N.A. (the “Computershare”(“Computershare”), the Corteva common stock owned on the record date by you directly in

Corteva 2024 Proxy Statement | 1

VOTING AND ATTENDANCE PROCEDURES

registered form, plus all shares of common stock held for you at Computershare, will appear together on a single proxy voting form. If no instructions are provided by you on an executed proxy voting form, your shares at Computershare will be voted as recommended by the Board.

Participants in various employee savings plans will receive a voting instruction form. Your executed form will provide voting instructions to the respective plan trustee. If no instructions are provided, the plan trustees and/or administrators for the relevant employee savings plan will vote the shares according to the provisions of the relevant employee savings plan. To allow sufficient time for voting, your voting instructions must be received by 11:59 P.M.p.m. Eastern Daylight Time (“EDT”) on April 23, 2020.2024. You may not vote your shares held in an employee savings plan in person at the Annual2024 Meeting.

Shares Outstanding and Quorum

VOTING AND ATTENDANCE PROCEDURES

respect to any such proposal, i.e., (i) FOR the election of the Board’s 13 director nominees; (ii) FOR the non-binding advisory resolution approving the compensation paid to Corteva’s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion; (iii) FOR the ratification of the appointment of PwC as Corteva’s independent public accounting firm for fiscal year 2024; and (iv) FOR the approval of an amendment of Corteva’s Certificate of Incorporation to provide for the exculpation of certain of our officers as permitted by Delaware law. If you submit a proxy card marked “abstain” on any item, your shares will not be voted on that item so marked and your vote will not be included in determining the number of votes cast on that matter.

If your shares are held of record by a bank, broker, or other nominee, Corteva urges you to give instructions to your bank, broker, or other nominee as to how you wish your shares to be voted so you can ensure your shares are voted at the 2024 Meeting.

As of the date of this Proxy Statement, the Board knows of no business other than that set forth above to be transacted at the 2024 Meeting, but if other matters requiring a vote do arise, it is the intention of the persons named in the proxy card to whom you are granting your proxy to vote in accordance with their good faith business judgment as to what is in the best interests of Corteva on such matters.

Proxy Solicitation on Behalf of the Board

The BoardCorteva is soliciting proxies to provide an opportunity for all stockholders to vote, whether or not the stockholders are able to attend the 20202024 Meeting or an adjournment or postponement thereof. Directors, officers and employees may solicit proxies on behalf of the Company’s Board in person, by mail, by telephone or by electronic communication. The proxy representatives of the Board will not be specially compensated for their services in this regard. Corteva will reimburse brokers and other nominees for their expenses in forwarding proxy solicitation materials to holders.

Attending the 20202024 Meeting

This year our 2020Our 2024 Meeting will be a completely virtual meeting with no physical meeting location. The meeting will only be conducted via live webcast. We believe this format will allow for greater participation of our stockholders generally, and in light ofreduced expense to the coronavirus outbreak (“COVID-19”), is consistent withCompany and the Company’s core values to live safely.environment. Conducting a virtual meeting will also allow stockholders whose travel may be restricted due to COVID-19 to partake in the meeting.

Attendance at the 2024 Meeting or any adjournment or postponement thereof will be limited to stockholders of the Company as of the close of business on the record date and invited guests of the Company. To participate in the virtual meeting, visit www.virtualshareholdermeeting.com/CTVA2020CTVA2024 and enter the 16-digit control number included on your notice of Internet availability of the proxy materials, on your proxy card, or on the voting instructions that accompanied your proxy materials. You

We are committed to ensuring our stockholders have the same rights and opportunities to participate in the 2024 Meeting as if it had been held in a physical location.

Stockholders may begin to log into www.proxyvote.com if they want to submit questions in advance of the meeting platform beginningmeeting. Pre-meeting questions will be cut-off at 10:30 a.m. CDT11:59 p.m. EDT on April 28, 2020. 22, 2024 to provide the Company time to respond and post both the questions and responses at the 2024 Meeting.

The meeting2024 Meeting will begin promptly at 11:8:00 a.m. CDTEDT on April 28, 2020.26, 2024 and stockholders will have another opportunity to ask questions during the meeting. If you want to submit your question during the meeting, log into the virtual meeting platform at www.virtualshareholdermeeting.com/CTVA2024, type your question into the “Ask a Question” field, and click “Submit.”

Corteva 2024 Proxy Statement | 3

VOTING AND ATTENDANCE PROCEDURES

The virtual meeting platform is fully supported across browsers (Internet Explorer,(MS Edge, Firefox, Chrome, and Safari) and devices (desktops, laptops, tablets, and cell phones) running the most updated version of applicable software and plugins. Participants should ensure that they have a strong Wi-Fi connection wherever they intend to participate in the meeting. Participants should also give themselves plenty of time to log in and ensure that they can hear streaming audio prior to the start of the meeting.

We are committedwill have technicians ready to ensuring our stockholdersassist you with any technical difficulties you may have accessing the same rights and opportunities to participate in the 2020 Meeting as if it been held in a physical location.virtual meeting. If you wish to submit a questionencounter any difficulties accessing the virtual meeting duringcheck-in or the meeting, you may log into www.proxyvote.com and enter your 16-digit control number. Once pastplease call the login screen, clicktechnical support number that will be posted on “Question for Management,” type in your question, and click “Submit.” Alternatively, if you want to submit your question during the meeting, log into the virtual meeting platform at www.virtualshareholdermeeting.com/CTVA2020, type your question into the “Ask a Question” field, and click “Submit.”

Questions pertinent to meeting matters will be answered during the meeting, subject to time constraints. Questions regarding personal matters, including those related to employment or product or service issues, are not pertinent to meeting matters and therefore will not be answered.

2  |  Corteva 2020 Proxy Statement

CORPORATE GOVERNANCE

Strong corporate governance is an integral part ofsupports our core values, and, as a result, Corteva is committed to applying the same sound corporate governance practices.practices, which align with the interests of our stockholders and ensure the highest levels of integrity in the operation of our Board. Within this section, you will find information about our Board and corporate governance policies and practices.

BOARD OF DIRECTORS

Nomination Process.All candidates for Board membership are evaluated by the NominationGovernance and GovernanceCompliance Committee. In evaluating candidates, including existing Board members, the NominationGovernance and GovernanceCompliance Committee considers an individual candidate’s personal and professional responsibilities and experiences, the then-current composition of the Board, the diversity of the then-current board and the challenges and needs of the Company in an effort to ensure that the Board, at any time, is comprised of a diverse group of members who, individually and collectively, best serve the needs of the Company and its stockholders. The NominationGovernance and GovernanceCompliance Committee may also consider recommendations from leading, global third-party search firms, whose function is to assist in identifying qualified candidates and to validate the background and reputation of any potential candidates. In general, and in giving due consideration to the composition of the Board at the time a candidate is being considered, the NominationGovernance and GovernanceCompliance Committee considers aeach potential nominee or director’s:nominee’s:

Inclusion. The Board is committed to diversity and inclusion and supportive of board candidates from underrepresented communities. We have taken steps to attract and retain Board candidates from diverse backgrounds, including with respect to skills, education, professional experience, personal attributes, gender, ethnicity, race, nationality, and age. When selecting Board candidates, the Board is focused on the individual’s experience in the context of the needs of the Board in the pool of potential candidates under consideration, while balancing the need to identify candidates for nomination that add to, or otherwise complement, the skills and experience.qualifications of its existing members through regular refreshment of our Board. During any Board refreshment process, we are mindful that we want the best talent for our Board and that our Board aspires to be representative of the communities and geographies in which we operate.

CORPORATE GOVERNANCE

4  |  Corteva 2020 Proxy Statement

CORPORATE GOVERNANCE

The Board is committed to strong, independent oversight of management and risk through a governance structure that includes otherour Board committees. Under our structure, it is management’s responsibility to manage risk and bring to the Board’s attentionidentify risks that are materialsignificant to the Company. The Board has oversight responsibility for the process established to report and monitor the most significant risks applicable to the Company. The Board administers its risk oversight role directly and through its committee structure and the committees’committees provide regular reports to the full Board at Board meetings. The Board divides its risk oversight responsibilities between itself and its committees by having each review or assess key issues or areas of responsibility as follows:

Board Term.Our Certificate of Incorporation provides that all directors stand for election at each annual meeting of stockholders. Our Corporate Governance Guidelines provide that effective beginning at the 2021 annual meeting of stockholders, no director may stand for reelection toMeetings. During 2023, the Board after reaching age 75. The delayed effectiveness of this retirement policy allows for a transition period for Mr. Thomas who has played an important role in setting the strategy for

Corteva 2020 Proxy Statement  |  7

Limits on Other Directorships.Pursuant to our Corporate Governance Guidelines, directors who are employed as an executive officer of another public company may only serve on a total of two public company boards, including the Boardboard of the company with which he or she is employed. Additionally, directors, who are not current executive officers of a public company, may serve on a maximum of threefour public company boards, including our Board.

Our current outside directorship limits are set at a level that allow the Company to compete for board talent with the appropriate levels of expertise and experience needed to provide effective oversight for our industry. Because the agriculture industry is consolidated, ensuring sufficient agriculture executive experience and expertise for our Board can be challenging. Our directors whowith the highest number of directorships are not also executive officers of a public company, may serve on a maximum of fourMessrs. Page and Everitt with three other public company boards includingeach. Messrs. Page and Everitt each have over 35 years of global executive experience in the agricultural industry, along with experience as directors of agricultural companies, which is important to Corteva as a relatively new standalone agricultural company with a recently refreshed management team. See Agenda Item 1: Election of Directors for more information on their specific skills, expertise and experience. Both Messrs. Page and Everitt are retired and had solid levels of stockholder support last year, as well as strong aggregate Board and committee attendance of 96% and 90%, respectively, in 2023. Additionally, consistent with our committee chair rotation policies, Ms. Giesselman replaced Mr. Page as chair of the Governance and Compliance Committee on February 20, 2024, providing Mr. Page further bandwidth as our Chair.

Board until December 31, 2021Refreshment. As part of the Company’s Board refreshment process, our Certificate of Incorporation provides that all directors stand for election at whicheach annual meeting of stockholders. Our Corporate Governance Guidelines provide that no director may stand for reelection to the Board after reaching age 75. The Board may in unusual circumstances and for a limited period of time anyask a director to stand for reelection after the prescribed retirement date.

Committee Refreshment. The Governance and Compliance Committee evaluates its Committee composition and committee chairs for potential changes annually. The Board expects to rotate its Committee chairs every 5 years, with the incoming Committee chair serving on such director must resign or reducecommittee for a minimum of one year prior to his or her serviceappointment. The outgoing committee chair is expected to serve on such Committee for a minimum of an additional year to ensure an orderly transition. Under the Company’s Corporate Governance Guidelines, while the Board is expected to generally follow the principles above, the Board also may take into account Company facts and circumstances, and any other factors the Board believes are appropriate, to determine whether rotation of the committee chairs is appropriate and to select the individuals best-suited to serve in these roles.

Board Annual Performance Reviews. Under the Company’s Corporate Governance Guidelines, the Board annually conducts a self-evaluation of the Board’s performance as a whole. In addition, the Board annually evaluates individual director performance and effectiveness, with a minimum of one-third of the directors being evaluated each year on a staggered basis. The performance and effectiveness of each standing committee of the Board is also evaluated on an annual basis in accordance with their respective written charter. At least every three public company boards.years, an evaluation of the Board’s performance and effectiveness will be conducted by an independent, third party overseen by the Governance and Compliance Committee. This may be conducted in substitute of, or separate from, an internally administered annual self-evaluation of the Board’s performance.

8 | Corteva 2024 Proxy Statement

CORPORATE GOVERNANCE

EVALUATION PROCESS REVIEW

WRITTEN QUESTIONNAIRES

EVALUATIONS AND WRITTEN REPORTS

REVIEW RESULTS

ACT ON RESULTS

Governance and Compliance Committee reviews the design and format of the annual Board, committee, and director evaluation process.

Directors complete written questionnaires to assess the Board and each committee. The independent board chair or another facilitator conducts one-on-one interviews with each director.

Responses are evaluated and written reports with the assessment results and comments without attribution to individual directors are prepared for the Board and each committee.

The chair of the Governance and Compliance Committee review the board assessment results with the full Board and individual director assessments with the individual directors. The chair of each committee reviews its assessment with the respective committee.

Results of assessment reviews inform changes to policies, practices, and procedures; future Board and committee agendas; and Board refreshment and committee rotation decisions.

		Our Board, Committee, and individual director evaluations are collectively designed to solicit input and perspective on various topics, including:
		•  Board structure, size, and composition, including director skills, diversity, and experience, and the need for Board refreshment •  Committee structure and allocation of responsibilities •  Conduct of meetings, including cadence, length, and opportunity for director input and meaningful discussion •  Materials and information, including quality, timeliness, and relevance •  Future agenda topics and priorities for the Board and its committees		•  Director orientation and education •  Director performance, including attendance, preparation, and participation •  Access to management and internal and external experts, resources, and support •  Committee process, member and chair performance, and management support •  Performance of the Board chair, including communication, relationship with management, availability, focus on appropriate issues, and inclusiveness

Stock Ownership Policy for Non-Employee Directors. The Company’s Corporate Governance Guidelines provide stock ownership guidelines, which require non-employee directors to own within five years from their respective appointment date, five (5) times their annual cash retainer in equity of the Company. Each non-employee director is also required to hold all equity-based compensation until the director meets the stock ownership guideline. For more information about the stock ownership policy for executive officers, please see the “Compensation Discussion and Analysis” section of this Proxy Statement.

Executive Sessions.Pursuant to our Corporate Governance Guidelines, the independent directors meet in regularly scheduled executive sessions. The Chair presides over these meetings.meetings and generally occur with each regularly scheduled meeting of the Board.

Corteva 2024 Proxy Statement | 9

Code of Conduct.We have adopted a written Code of Conduct for directors as well as a Code of Conduct applicable to all officers and employees. Additionally, we maintain a written Code of Financial Ethics, applicable to our principal executive officer, principal financial officer, principal accounting officer, controller, and all employees performing similar functions. These policies are designed to maintain the integrity of our business, as well as the accuracy of our financial reporting. These codes cover, among other things, professional conduct, conflicts of interest, accurate recordkeeping and reporting, public communications, and the protection of confidential information, as well as adherence to laws and regulations applicable to the conduct of our business. Copies of these documents are available free of charge on the “Corporate Governance”“Governance” section of the Company’s website at www.investors.corteva.comhttps://investors.corteva.com or otherwise upon written request addressed to Corteva, Inc., 974 Centre Road, Building 735, Wilmington, Delaware, 19805, Attention: Investor Relations.

Board Annual Performance Reviews.Pursuant to our Corporate Governance Guidelines the Board annually conducts a self-evaluation of the Board’s performance as a whole. Additionally, in accordance with the written charters of our audit committee, people and compensation committee, nomination and governance committee, and sustainability, safety, and innovation committee, we also evaluate each committee’s performance on an annual basis. The Company used a questionnaire to facilitate an assessment of how well each committee has performed the responsibilities listed in its charter, as well as the quality of the Board and committee meeting agendas, materials and discussions. All assessments and evaluations focus on both strengths and opportunities for improvement and are shared with the Board. Despite the abbreviated year, the Nomination and Governance Committee performed self-evaluations of the Board and its respective committees, which reflected overall effective performance. The outcomes of these performance evaluations may be used to facilitate future Board succession planning, the formulation of Board and committee agendas, and the reviews of the Company’s Corporate Governance Guidelines, committee composition, and committee charters.

8  |  Corteva 2020 Proxy Statement

CORPORATE GOVERNANCE

A brief description of the current composition and responsibilities of the Committees are as follows:

Committees

KEY RESPONSIBILITIES:

All members of the Audit Committee are independent directors under the Board’s Corporate Governance Guidelines and applicable regulatory and listing standards.

The Board has determined that Messrs. Engel, Lutz, Page, and Ward are each “audit committee financial experts” within the meaning of applicable SEC rules.

GOVERNANCE AND COMPLIANCE COMMITTEE		Number of Meetings in 2023: 5

KEY RESPONSIBILITIES:

Corteva 20202024 Proxy Statement | 911

CORPORATE GOVERNANCE

KEY RESPONSIBILITIES:

All members of the Nomination and Governance Committee are independent directors under the Board’s Corporate Governance Guidelines and applicable regulatory and listing standards.

All members of the People and Compensation Committee are independent directors under the Board’s Corporate Governance Guidelines and applicable regulatory and listing standards.

1012 | Corteva 20202024 Proxy Statement

CORPORATE GOVERNANCE

Sustainability, Safety, and Innovation Committee All members of the Sustainability, Safety, and Innovation are independent directors under the Board’s Corporate Governance Guidelines. SUSTAINABILITY AND INNOVATION COMMITTEE (“S&I”)		•  Assesses the effectiveness	Number of and advises the Board on, corporate responsibility programs and initiatives, including the Company’s public policy, environment, health and safety (“EH&S”) and sustainability policies and programs and matters impacting the Company’s public reputation. •  Oversees and advises the Board on the Company’s corporate citizenship and corporate social responsibility programs and activities, including public policy management, advocacy priorities, philanthropic contributions, and corporate reputation management. •  Reviews the Company’s public policy positions, strategy regarding political engagement and corporate social responsibility initiatives. •  Assesses the Company’s EH&S and sustainability policies and performance and makes recommendations to the Board and management regarding the same. •  Reviews and provides input to management regarding the management of current and emerging EH&S and sustainability issues and reports periodically to the Board on EH&S and sustainability matters affecting Corteva. •  Oversees and assesses all aspects of the Company’s science and technology capabilitiesMeetings in all phases of its activities in relation to its strategies and plans, including the development of key technologies and major science-driven innovation initiatives essential to the long-term success of the Company. 2023: 6
				•  Makes recommendations to the Board and the management of the Company to continually enhance the Company’s science and technology capabilities, including reviewing the Company’s external science and technology alliances and licensing arrangements.

KEY RESPONSIBILITIES:

2023 Committee Membership

Because allAll of our standing committees consist entirely of independent directors, Messrs. Breen and Collins aredirectors. Therefore, Mr. Magro does not serve as a member of any of our standing committees.Committees. A list of the independent directors and their respective Committee memberships for 2023 is below:set forth below. Ms. Giesselman became the Governance and Compliance Committee chair effective February 20, 2024.

C = Chair

Corteva 20202024 Proxy Statement | 1113

RELATED PERSON TRANSACTIONS

OUR POLICIES

The Board adopted written policies and procedures relating to the approval or ratification of each “Related Person Transaction.” Under the policies and procedures, the NominationGovernance and GovernanceCompliance Committee (or any other committee comprised of independent directors designated by the Board) reviews the relevant facts of all proposed Related Person Transactions and either approves, disapproves, or ratifies the entry into a particular Related Person Transaction, by taking into account, among other factors it deems appropriate:

No Director may participate in any discussion or approval of a Related Person Transaction for which he/she or any of his/her immediate family members is the Related Person. Related Person Transactions are approved or ratified only if they are determined to be in the best interests of Corteva and its stockholders.

If a Related Person Transaction that has not been previously approved or previously ratified is discovered, the Related Person Transaction will be presented to the NominationGovernance and GovernanceCompliance Committee for ratification. If the NominationGovernance and CorporateCompliance Committee does not ratify the Related Person Transaction, then the Company either ensures all appropriate disclosures regarding the transaction are made or, if appropriate, takes all reasonable actions to attempt to terminate the Company’s participation in the transaction.

Under Corteva’s policies and procedures, a “Related Person Transaction” is generally any financial transaction, arrangement, or relationship (including any indebtedness or guarantee of indebtedness) or any series of similar transactions, arrangements, or relationships in which:

A “Related Person” is generally any person who is, or at any time since the beginning of Corteva’s last fiscal year was:

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

In connection with the Distributions and Separation, Corteva entered into certain agreements to effectuate the Separation, to provide for the allocation of assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the DuPont, Dow, and Corteva (together, the “Parties” and each a “Party”); and to provide a framework for business dealings between the parties following the Separation and Distribution. Descriptions of these agreements are incorporated by reference from “Our Relationship with New DuPont and Dow Following the Distribution” in Exhibit 99.1 to the Company’s Registration Statement on Form 10, dated May 6, 2019 and Item 1.01 of the Company’s Current Report on Form 8-K, dated June 3, 2019. All descriptions therein and below are qualified in their entirety by reference to the full text of such final, executed agreements filed therewith.

Separation and Distribution Agreement.Effective April 1, 2019, the Parties entered into an agreement that sets forth, among other things, the agreements among the Parties regarding the principal transactions necessary to affect the

1214 | Corteva 20202024 Proxy Statement

ESG INITIATIVES AND OUR VALUES

and practices. Somethe Task Force on Climate-Related Financial Disclosures (“TCFD”). In 2023, Corteva participated in two Task Force on Nature-related Financial Disclosures (“TNFD”) pilots to guide the development of these key policiesthe TNFD and practicesto better understand our nature-related opportunities and dependencies, as well as how to integrate nature-related risks into our decision-making processes. More information may be found in our next sustainability report, which is expected to be published in early April 2024 on our investor website, https://investors.corteva.com.

The Company’s sustainability programs and strategy is gaining the Company recognition for its efforts.

		•  Corteva was named one of the “World’s Most Admired Companies” for 2024 by Forbes, ranking #1 in food production and #118 overall among a pool of approximately 1,500 U.S. and global companies. •  Corteva was named a “Best Place to Work for Disability Inclusion”, for 2023 by the Disability Inclusion Index. The Disability Inclusion Index is the leading independent, third-party resource for the annual benchmarking of corporate disability inclusion policies and programs, with 70% of the Fortune 100 and nearly half of the Fortune 500 utilizing its benchmarking.

Ethical and Secure Supply Chains

Corteva’s largely multi-sourced supply chains are described below.

Supplier Code of Conduct. Corteva maintains a Supplier Code of Conduct designed to setbe resilient and reflect the high expectations Corteva sets for ourits suppliers. Corteva expects its suppliers alignedto act consistently with Corteva’s values and to establish the Company’sabide by our Supplier Code of Conduct, which establishes our policies with respect to:to fair wages, discrimination, human rights, ethical procurement practices, record-keeping, and the compliance with applicable laws. Our Supplier Code of Conduct may be found under the “Supplier Center” section of our website: supplier-center.corteva.com.

Child and Forced Labor Statement: Corteva will not tolerate the use of child or forced labor in any of its global operations and facilities. We, likewise, expect our suppliers and contractors to uphold our principles with respect to child and forced labor. Our Supplier Code of Conduct and Child and Forced Labor Statement may be found under the “Supplier Center” section of our website:supplier-center.corteva.com.https://www.supplier-center.corteva.com/.

Political Activities:Activities

Corteva is committed to participating constructively in the political process with the ultimate goals of advancing and protecting the best interests of the Company, our stockholders, and employees. The political process significantly impacts Corteva through government policies, legislation, and regulatory decisions. We are fully committed to conducting our political activities ethically and in compliance with our policies and all applicable campaign finance laws and reporting requirements. In 2023, Corteva was named one of the fourth quarter 2019, Corteva spent approximately $523,079top decile of companies in lobbying activities. While the majorityWharton’s Zicklin Center for Political Accountability’s “CPA-Zicklin Index” earning trendsetter status for its high level of this spend wastransparency. More information related to compensationCorteva’s policies and its political spending can be found at: https://www.corteva.com/who-we-are/political-disclosures.html.

Human Capital Management

We believe that attracting, retaining, and developing members of our workforce is key to the sustainability of our business and developing our pipeline for leadership. Our leadership is focused on fostering an environment in which employees are contributing fully and able to win for themselves, for Corteva and for our customers and stockholders. Corteva aims to attract the best employees, to retain those employees through offering career development and training opportunities while also prioritizing their safety and wellness in an inclusive and productive work environment. In order to promote this environment, Corteva prioritizes professional development and inclusion, diversity, and equity initiatives, and then monitors their effectiveness by measuring employee engagement, employee representation, and pay equity, along with reviews of its leadership succession pipelines.

We believe by supporting inclusion, diversity, and equity initiatives for employees of all backgrounds, Corteva can retain and attract the best talent and nurture a workforce with a greater variety of skills, perspectives, backgrounds and experiences, which we expect to foster the diversity of thought needed to drive our innovative culture into the future.

Led by Corteva’s Chief Human Resources and Diversity Officer, Corteva has undertaken the following inclusion, diversity and equity practices set forth in the table below. For more information on Corteva’s inclusion, diversity and equity (ID&E) practices, see Corteva’s website, www.corteva.com/who-we-are/our-diversity.html.

16 | Corteva 2024 Proxy Statement

ESG INITIATIVES AND OUR VALUES

The Company’s in-house lobbying personnelinclusion efforts are supported by nine business resource groups. These business resource groups are open to all employees and outside government affairs consultants, $29,050 were contributions to political committeesimplement programs focused on embracing the similarities and $24,530 related to dues payments allocated to lobbying performed by agricultural trade associationsdifferences of which Cortevapeople, cultures, and ideas, and fostering the professional development and engagement of their members.

The People and Compensation Committee conducts regular reviews of the Company’s leadership pipelines for its business lines and critical functions. During these reviews, long-term and emergency succession plans, talent development, and the diverse representation within the leadership pipeline is a member.evaluated. Corteva’s management supports employee professional and personal growth through learning through various programs and efforts described in the table below.

Corteva 20202024 Proxy Statement | 1517

AGENDA ITEM 1:

ELECTION OF DIRECTORS

BOARD COMPOSITION

TheOur Board is elected annually and currently consists of thirteen members, with Mr. Page serving as its Chair.

Our Board believes in maintaining a diverse and well-rounded membership, complete with qualifications, skills, and experience that support not only the Company’s business needs, but that also provide a current, holistic approach to the Company’s business model as a whole. Our Board has developed a deep and varied skill set, with a membership that reflects a comprehensive spectrum of both professional and personal experiences. The Board is elected annually. In February 2020, Edward Breen indicated that he would not stand for re-electioncommitted to diversity and inclusion at the 2020 MeetingBoard level and has taken steps to identify and attract diverse candidates with respect to skills, experience, education, gender, ethnicity, race, nationality, and age, skills, and experience in the context of the needs of the Board subsequently appointed Ms. Nayyarin the pool of potential candidates under consideration, while balancing the need to identify and attract candidates for nomination that add to, or otherwise complement, the skills and qualifications of its existing members through regular refreshment of our Board. For the 2020 Meeting, the Board intends to close the seat vacated by Mr. Breen.

The proposed twelve director nominees collectively possessGovernance and Compliance Committee, along with our Board, believe that our stockholders benefit from a varietyBoard drawing upon a broad array of skills, professional experience,experiences and diversity of backgrounds that allow them to effectively oversee Corteva’s business including: leadership experience; international experience; operational experience in agriculture, manufacturing, chemicals, and technology; public company board experience; board or other significant experiencebackgrounds. Consistent with trade and industry organizations and academic research institutions; and prior government or public policy experience. All of the director nominees, except for Mr. Collins, are independent under the New York Stock Exchange listing standards.

RECOMMENDATIONS AND NOMINATIONS FOR DIRECTOR

In accordance with the recommendation of the Nomination and Governance Committee,our priorities, the Board has nominated twelve individuals listed ina diverse slate of candidates consisting of: Lamberto Andreotti; Klaus A. Engel; David C. Everitt; Janet P. Giesselman; Karen H. Grimes; Michael O. Johanns; Rebecca B. Liebert; Marcos M. Lutz; Charles V. Magro, Nayaki R. Nayyar; Gregory R. Page; Kerry J. Preete; and Patrick J. Ward. The below metrics regarding our director nominee slate demonstrates the following table for election as Directors, to serve for a one-year term that expires at the Annual Meeting in 2021 or until their successors are elected and qualified.results of our ongoing refreshment priorities.

18 | Corteva 2024 Proxy Statement

AGENDA ITEM 1: ELECTION OF DIRECTORS

The Governance and Compliance Committee and the Board carefully considered the qualifications, skills, and experience of each nominee when concluding that this year’s nominees should serve on the Board. The chart below highlights certain of the diverse sets of skills, knowledge, background, attributes, and experience that are represented on our Board: